Joinn Laboratories (China) Co Ltd

603127

Company Profile

  • Business description

    Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non-Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.

  • Contact

    A5 Rongjing East Street
    Beijing Economic-Technological Development Area
    Beijing100176
    CHN

    T: +86 1067869966

    https://www.joinnlabs.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    2,649

Stocks News & Analysis

stocks

Updating our commodity price assumptions

Our view as China’s steel production drops.
stocks

Higher credit stress for big four bank

Shares fall after announcement that capital will be replenished for loan impairment provisions.
stocks

The ASX player evolving into a defensive haven

A well-timed simplification journey as boring evolves back in vogue.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,177.1016.10-0.18%
CAC 408,235.7295.32-1.14%
DAX 4024,270.87146.93-0.60%
Dow JONES (US)49,318.76123.80-0.25%
FTSE 10010,498.09110.99-1.05%
HKSE26,487.48126.410.48%
NASDAQ24,388.0816.31-0.07%
Nikkei 22559,349.17873.271.49%
NZX 50 Index12,932.3326.660.21%
S&P 5007,095.5613.58-0.19%
S&P/ASX 2008,949.4020.10-0.22%
SSE Composite Index4,085.082.950.07%

Market Movers